|
|
|
|
| LEADER |
00000nab a2200000uu 4500 |
| 001 |
vtls011501102 |
| 003 |
SK-MaSNL |
| 005 |
20260303182522.0 |
| 008 |
230222|2013 xo |||||||||||||||||eng| |
| 015 |
|
|
|a SNBRB
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a0ag03
|
| 035 |
|
|
|a (uuid)19b69d5d-2d0d-4c72-974b-88cf3b549e97
|
| 035 |
|
|
|a urn:nbn:sk:snk-abdvix
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 100 |
1 |
|
|a Chiang, F. F.
|4 aut
|9 1210442
|
| 245 |
1 |
0 |
|a Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients
|c F. F. Chiang, H. M. Wang, M. C. Chen
|
| 700 |
1 |
|
|a Wang, H. M.
|4 aut
|9 1200974
|
| 700 |
1 |
|
|a Chen, M. C.
|4 aut
|9 1210443
|
| 773 |
0 |
|
|t Neoplasma : journal of experimental and clinical oncology
|g Roč. 60, č. 5 (2013), s. 561-567
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 958 |
|
|
|a article20
|
| 999 |
|
|
|c 2117321
|d 2119251
|
